Cross-institution positioning
Apr 24, 2026Accumulation leaning. 1 accumulating across 1 comparable institution.
Source: Schedule 13 researchEMERA INC
Latest stored close $45.85 as of Oct 8, 2026 View live quote ↗
See how each tracked institution's reported ownership changed across SEC position dates. Full history is available with Investor or Pro access.
What the evidence shows across the newest institutional, insider, company-event, 13F, fundamental, and price data; STOCKNODE combines these layers into a quantitative research signal while preserving each source and reporting window.
Accumulation leaning. 1 accumulating across 1 comparable institution.
Source: Schedule 13 research1 increased/new, 0 reduced/exited across 1 manager in the latest comparable Form 13F quarter.
Source: Form 13F quarter-end holdingsLatest classified evidence: Prospectus filing. Registration and prospectus filings are treated as financing capacity/disclosure evidence, not proof that securities were sold.
Source: SEC 8-K / securities filing metadataRevenue +21.9% YoY; Net income +91.9% YoY. Periods are compared only when the SEC facts are aligned and comparable.
Source: SEC Company FactsRecent close is 27% through its reported 52-week range; +3.4% over one year.
Source: Stored historical price seriesFiled Apr 24, 2026. Unlock the dated position comparison, disclosure classification, confidence, price context, and filing-specific significance analysis.
Premium research values are withheld until unlocked.
The research summary above gives the current read. This section shows the dated holder-level evidence behind it.
See each institution's newest reported position against its own prior report, with position as-of date separated from SEC filed date. Institution names and filing freshness remain public below.
Comparable holder direction grouped by SEC position as-of date — never presented as trade dates.
Compare each institution only with its own prior reported position. Public visitors can see who is tracked and how fresh the filing is; paid research reveals the actual comparison.
Investor and Pro reveal holder-by-holder changes, reported ownership history, dated breadth, disclosure timing, institution comparison, and filing-specific analysis without treating Schedule 13 reports as trade dates.
Recent 8-K item classifications plus securities registration and prospectus filings. Registration or prospectus filings show financing capacity/disclosure activity; they do not by themselves prove that securities were sold.
Period-aligned SEC facts. Comparisons appear only when periods and units are comparable.
| Period | Revenue | YoY |
|---|---|---|
| Ended Dec 31, 2025 | 8.8B CAD | +21.9% |
| Ended Dec 31, 2024 | 7.2B CAD | -4.8% |
| Ended Dec 31, 2023 | 7.6B CAD | -0.3% |
| Ended Dec 31, 2022 | 7.6B CAD | +31.6% |
Dated price context from the historical market series already collected for this security.
Returns are close-to-close price changes. Volatility and drawdown are factual historical context, not recommendations.
Schedule 13G/13D reports beneficial ownership at an observation date. “Accumulation” or “reduction” is inferred from changes in reported shares when available; it is not a list of individual trades or exact execution prices.
Form 13F rows are quarter-end holding context only and do not establish an exact entry date.
For more context, see how to read a Schedule 13G, filing date vs event date, or Schedule 13G vs Schedule 13D.
| Holder | Observed / filed | Reported change | Shares | Ownership | Observation | Filing | Latest |
|---|---|---|---|---|---|---|---|
| BlackRock CIK0002012383 | Mar 31, 2026 observed Apr 24, 2026 filed · 24d Schedule 13G amendment | Earliest Schedule 13G amendment found | 20.9M | 12.00% | $51.87 | $52.58 | $45.85 |
| BlackRock CIK0002012383 | Jun 30, 2025 quarter end Aug 12, 2025 filed Form 13F quarter-end evidence | Earlier Form 13F quarter-end holding Quarter-end holding evidence; no ownership percentage or signal. | 1.4K | $45.85 | |||
| BlackRock CIK0001364742 | Dec 31, 2023 observed Feb 2, 2024 filed · 33d Initial Schedule 13G | Initial Schedule 13G | 15.2M +1.8M | 5.50% +0.51 pts | $37.79 | $35.99 | $45.85 |
Compare EMA with other securities showing similar institutional activity or recent accumulation across several tracked institutions.